CN103550126A - Biological acne-removing and scar-lightening repairing emulsion - Google Patents
Biological acne-removing and scar-lightening repairing emulsion Download PDFInfo
- Publication number
- CN103550126A CN103550126A CN201310551592.1A CN201310551592A CN103550126A CN 103550126 A CN103550126 A CN 103550126A CN 201310551592 A CN201310551592 A CN 201310551592A CN 103550126 A CN103550126 A CN 103550126A
- Authority
- CN
- China
- Prior art keywords
- gram
- grams
- acne
- skin
- hirudin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010000496 acne Diseases 0.000 title abstract description 12
- 208000002874 Acne Vulgaris Diseases 0.000 title abstract description 11
- 239000000839 emulsion Substances 0.000 title abstract 6
- 102000007625 Hirudins Human genes 0.000 claims abstract description 21
- 108010007267 Hirudins Proteins 0.000 claims abstract description 21
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 claims abstract description 21
- 229940006607 hirudin Drugs 0.000 claims abstract description 21
- 150000001413 amino acids Chemical class 0.000 claims abstract description 17
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims abstract description 17
- 101800003838 Epidermal growth factor Proteins 0.000 claims abstract description 16
- 102000000588 Interleukin-2 Human genes 0.000 claims abstract description 16
- 108010002350 Interleukin-2 Proteins 0.000 claims abstract description 16
- 229940116977 epidermal growth factor Drugs 0.000 claims abstract description 16
- 210000002826 placenta Anatomy 0.000 claims abstract description 14
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 210000002374 sebum Anatomy 0.000 claims abstract description 9
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 7
- 102000014171 Milk Proteins Human genes 0.000 claims abstract description 7
- 108010011756 Milk Proteins Proteins 0.000 claims abstract description 7
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 7
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 7
- 235000021239 milk protein Nutrition 0.000 claims abstract description 7
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract description 7
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 7
- 229940011671 vitamin b6 Drugs 0.000 claims abstract description 7
- 102000009024 Epidermal Growth Factor Human genes 0.000 claims abstract 4
- 235000001014 amino acid Nutrition 0.000 claims description 15
- 235000018102 proteins Nutrition 0.000 claims description 14
- 102000004169 proteins and genes Human genes 0.000 claims description 14
- 108090000623 proteins and genes Proteins 0.000 claims description 14
- 241000283898 Ovis Species 0.000 claims description 13
- 230000003255 anti-acne Effects 0.000 claims description 12
- 210000000481 breast Anatomy 0.000 claims description 11
- 239000003906 humectant Substances 0.000 claims description 6
- 210000004698 lymphocyte Anatomy 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 239000000243 solution Substances 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 3
- 238000005457 optimization Methods 0.000 claims description 3
- 239000011550 stock solution Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 15
- 210000004369 blood Anatomy 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 13
- 230000003750 conditioning effect Effects 0.000 abstract description 7
- 230000004089 microcirculation Effects 0.000 abstract description 6
- 230000007969 cellular immunity Effects 0.000 abstract description 4
- 241001494479 Pecora Species 0.000 abstract description 3
- 208000003455 anaphylaxis Diseases 0.000 abstract description 3
- 230000002087 whitening effect Effects 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 abstract 2
- 239000003531 protein hydrolysate Substances 0.000 abstract 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 1
- 230000003712 anti-aging effect Effects 0.000 abstract 1
- 230000001153 anti-wrinkle effect Effects 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- -1 ethyl ascorbic acid Chemical compound 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
- 108700012359 toxins Proteins 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 28
- 102400001368 Epidermal growth factor Human genes 0.000 description 12
- 239000002537 cosmetic Substances 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 9
- 239000000126 substance Substances 0.000 description 6
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 241000700647 Variola virus Species 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 108090000190 Thrombin Proteins 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 210000004927 skin cell Anatomy 0.000 description 3
- 229960004072 thrombin Drugs 0.000 description 3
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000036783 anaphylactic response Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 230000003169 placental effect Effects 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000037380 skin damage Effects 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000002537 thrombolytic effect Effects 0.000 description 2
- 102000005606 Activins Human genes 0.000 description 1
- 108010059616 Activins Proteins 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 241000237903 Hirudo Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010040867 Skin hypertrophy Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000488 activin Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 210000003725 endotheliocyte Anatomy 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 1
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 229940044627 gamma-interferon Drugs 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229940000351 hemocyte Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 1
- 230000004719 natural immunity Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000037204 skin physiology Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention discloses a biological acne-removing and scar-lightening repairing emulsion. According to the formula, the biological acne-removing and scar-lightening repairing emulsion is composed of the following components: 10g-20g of sheep placenta protein hydrolysate, 5g-10g of hirudin, 3g-8g of interleukin-2, 1g-2g of an epidermal growth factor, 3g-5g of vitamin B6, 3g-5g of ethyl ascorbic acid, 6g-10g of sebum amino acid, 10g-15g of a milk protein, 3g-5g of an amino acid moisture keeping agent, 2g-3g of hyaluronic acid and 15g-25g of water. Compared with the prior art, the repairing emulsion has the advantages that the placenta protein hydrolysate and the hirudin are combined and fused into a skin-caring product for the first time; the repairing emulsion conforms to the principle that the skin condition is regulated radically through conditioning face blood microcirculation and the cell immunity is enhanced when the skin is repaired; the repairing emulsion has no irritation, no toxins and no anaphylactic reactions, and has whitening, anti-wrinkle, sun-proof, anti-aging and moisture-keeping effects and the like.
Description
Technical field:
The present invention relates to cosmetic field, specifically the light trace of a kind of biological anti-acne is repaired breast.
Background technology:
1, because the product type of cosmetics is varied, consumer promotes gradually to the requirement of cosmetics, especially more and more to the demand of green, environmental protection, harmless skin, biological cosmetics, especially female consumer, therefore, constantly research and develop organic-biological, natural, safer cosmetics become numerous cosmetics companies, biological study etc. win the favourable weapon of competitive market; 2, along with growth in the living standard, people also more and more pay attention to for facial fashion, not only require clean, the clean health that also requires musculus cutaneus skin, indefectible; As mainly in the generation of: acne stop up with hypersteatosis, pilosebaceous duct, the factor such as antibacterial infection and inflammatory reaction is closely related, adolescence is honest at life's full flowering, the comedo that endocrine regulation causes has become the topic that current teenager is concerned about most, product for resolving poxes in the market, otherwise be exactly not have effect, otherwise be exactly simple external treatment poor effect, even if produce effect, also cure the symptoms, not the disease, can not be from basic Acne treatment; After people adolesces in human body androgen particularly the level of testosterone raise rapidly, promote sebaceous gland to grow and produce a large amount of sebums, the dyskeratosis of pilosebaceous duct causes conduit to stop up simultaneously, dyssebacia, forming horn plug is that micropowder stings; Current most cosmetic product is all the manufacture of chemical industrial product extracting solution, the Chemical Engineer who is ignorant of Dermatology and skin physiology principle removes preparing cosmetics according to antiinflammatory, clean method, be easy to destroy skin cells of superficial layer, harmful substance in these chemical industry cosmetics has brought consumer great injury, the sebum film of heavy damage skin and the pH value of skin, thus make the too early shortcomings such as aging of skin.
Summary of the invention:
In order to solve the problem of stating, the invention provides that a kind of to take natural biological extract Placenta caprae seu ovis hydrolyzed protein thing, hirudin, epidermal growth factor (EGF) be active ingredient raw materials, utilize modern biological project purification, extraction to form, be applied in skin affected part, can remove acne and desalinate pockmark; Principle is for passing through conditioning face blood microcirculation, conditioning skin situation fundamentally, when repairing skin, strengthen cellular immunity, non-stimulated, nontoxic, without anaphylaxis, whitening, defying age, the effects such as moisturizing, recover skin damage for small pox (acne), pockmark specially and reach conditioning skin, promote blood microcirculation, suppress free radical, reduce melanocyte, effectively stop melanin route of synthesis, prevent the light trace of biological anti-acne of the function of all kinds of skin diseases to repair breast.
In order to solve the existing problem of background technology, the present invention is by the following technical solutions:
The light trace of a kind of biological anti-acne is repaired breast, consists of: Placenta caprae seu ovis hydrolyzed protein thing: 10-20 gram according to weight ratio following formula; Hirudin: 5-10 gram; Interleukin II: 3-8 gram; Epidermal growth factor: 1-2 gram; Vitamin B6: 3-5 gram; VCE: 3-5 gram; Sebum aminoacid: 6-10 gram; Milk protein thing: 10-15 gram; Amino acid humectant: 3-5 gram; Hyaluronic acid: 2-3 gram; Water: 15-25 gram.
Illustrate further as follows:
The optimization formula of various raw materials and weight ratio is composed as follows: Placenta caprae seu ovis hydrolyzed protein thing: 10 grams, hirudin: 5 grams, interleukin II: 3 grams, epidermal growth factor: 1 gram, vitamin B6: 3 grams, VCE: 3 grams, sebum aminoacid: 6 grams, milk protein thing: 10 grams, amino acid humectant: 3 grams, hyaluronic acid: 2 grams, water: 15 grams.
Described interleukin II is: lymphocyte interleukin II.
Described water is tri-distilled water.
The present invention has following beneficial effect:
The light trace of biological anti-acne the present invention relates to is repaired breast, be mainly used in the removing of facial small pox (acne) and the desalination of pockmark, its composition is formed by multiple bio-extract purification, extraction, have nontoxic, non-stimulated, without irritated, anti-acne (acne) is had to extraordinary effect, desalinate pockmark simultaneously, when being disappeared, small pox strengthens cellular immunity, improve human endocrine disorder, reduce the use of cosmetics, efficiently, function is wide, make skin recover normal physiologically active, promotes that skin better absorbs nutrient substance and cell metabolism; This product is comprised of biology formula, has the effects such as green, environmental protection, immunity, skin and complexion improving.
The specific embodiment of the present invention:
The light trace of a kind of biological anti-acne is repaired breast, consists of: Placenta caprae seu ovis hydrolyzed protein thing: 10-20 gram, hirudin: 5-10 gram according to weight ratio following formula; Interleukin II: 3-8 gram, epidermal growth factor: 1-2 gram, vitamin B6: 3-5 gram, VCE: 3-5 gram, sebum aminoacid: 6-10 gram, milk protein thing: 10-15 gram, amino acid humectant: 3-5 gram, hyaluronic acid: 2-3 gram, water: 15-25 gram.
Below in conjunction with embodiment, the present invention will be further described:
The optimization formula of various raw materials and weight ratio is composed as follows: Placenta caprae seu ovis hydrolyzed protein thing: 10 grams, and hirudin: 5 grams; Interleukin II: 3 grams, epidermal growth factor: 1 gram, vitamin B6: 3 grams, VCE: 3 grams, sebum aminoacid: 6 grams, milk protein thing: 10 grams, amino acid humectant: 3 grams, hyaluronic acid: 2 grams, water: 15 grams.
Described interleukin II is: lymphocyte interleukin II.
Described water is tri-distilled water.
Described hirudin, interleukin-2, epidermal growth factor are the dilatation solution of stock solution.
According to the formula described in embodiment, wherein function or the formula of part formula further illustrate as follows:
1, Placenta caprae seu ovis hydrolyzed protein thing: mention that ancient times, well-known doctor Li Gao once said on < < Compendium of Materia Medica > >: " all tastes and Carnis caprae seu ovis person; all can mend it; Carnis caprae seu ovis is mended shape, and ginseng qi-tonifying also." Placenta Hominis is always regarded as the product of large benefit.Have to integrate speed and treat and support unit, have the effect of nourishing blood to tranquillize the mind, rich flesh skin care, life lengthening, the nutrient protein thing extracting from Placenta caprae seu ovis, has the effect of nourishing blood to tranquillize the mind, rich flesh skin care, slow down aging.
2, hirudin: if separating-purifying out, has anticoagulant from the saliva of Hirudo, the peptide material of antithrombotic effect, the clinical treatment that is usually used in multiple thrombotic disease, can eliminate angiemphraxis, makes hemocyte depolymerization, thrombosis dissipates, and promotes blood capillary logical again, improves microcirculating state. at present, be usually used in regulating blood fat, eliminate fatty liver, directly dissolve thrombosis, eliminate atherosclerosis, prevent apoplexy and apoplexy again, the thrombolytic function of human activin self, avoids again producing thrombolytic etc.The N end of hirudin can be blockaded and doubt the avtive spot of hemase, nonpolar binding site (AB) complementation of its hydrophobic domains and thrombin, and this nonpolar binding site is near the catalytic center of thrombin.Hirudin C-terminal has 6 acidic amino acids, can form many ionic bonds with the thrombin recognition site of positively charged.Hirudin, except medicinal, can also be applied in health product and cosmetics, and its mechanism of action is as follows:
(1) autonomous directly infiltration: scientific research shows, it is≤8000 daltonian materials that human body cell can only absorb molecular weight under normal circumstances, the contained natural materials of the cosmetics sold is in the market as hyalomitome glue, collagen protein etc., its molecular weight is at several ten thousand hundreds of thousands even, be difficult to be absorbed by the skin, and hirudin molecular weight is only 7000 dalton, the deep layer that can penetrate to the skin is easily absorbed by Skin Cell.
(2) improve blood circulation: hirudin can reduce blood viscosity, accelerate blood flowing speed, dredging blood capillary, improves blood microcirculation, promotes skin metabolism, impels the self-regeneration of cell, makes skin exquisiteness, shrinks thick pore.
(3) nutrition skin: hirudin is polypeptides matter, polypeptide is by Amino acid profile but is different from the intermediate material of protein, it has the characteristic of protein, but simpler than protein, molecular weight is little, easily by body, absorbed, thereby its activity is high, micro-in the situation that, hirudin can be brought into play its unique physiological action.
(4) help and ooze, carry: can help other nutrient substance such as sheep placental extract to go deep into skin, the due beauty and skin care effect of performance sheep placental extract.
3, epidermal growth factor (is called for short: EGF): epidermal growth factor, epithelical cell growth factor is a kind of active substance in human body, by 53 amino living cells that form, by the tyrosine phosphorylation that stimulates EGFR, reach and repair hypertrophy skin cells of superficial layer, injured, impaired epidermis skin is had to excellent curative effect; Initial epidermal growth factor is mainly applied to medical domain, be mainly used in promoting reparation and the regeneration of impaired epidermis, its maximum feature is the proliferation and differentiation that can promote cell, thereby replace old and feeble and dead cell with newborn cell, epidermal growth factor can also stop blooding, and have and accelerate skin and mucosa wound healing, anti-inflammatory analgesic, prevent the effect of ulcer, the stability of epidermal growth factor is fabulous, be difficult at normal temperatures scattering mobile, can form good coordinating effect with various enzymes in human body.
4, interleukin-2: a kind of glycoprotein mainly being produced by lymphocyte, contain 133 aminoacid, molecular weight is 15600Kda, its mechanism of action: effectively participate in immunoreation, regulate the lymphocytic Proliferation and differentiation of T, natural immunity killer cell in can also stimulating immune system, T lymphocyte, the propagation of the killer cell (LAK) of tumor lympha cell (TIL) and Lymphokine, stimulate in addition B cell proliferation differentiation, secretory antibody, the secretion of the cytokine profiles such as induction gamma interferon, promote fibroblast, the growth of endotheliocyte, promote the formation of the synthetic and connective tissue of collagen protein, it is a kind of immunostimulant.
It is main effective ingredient that natural biological extract Placenta caprae seu ovis hydrolyzed protein thing, hirudin, epidermal growth factor are take in the present invention, utilize modern biological project purification, extraction to form, be applied in skin affected part, can remove acne and desalinate pockmark, compared with prior art, principle of the present invention is for passing through conditioning face blood microcirculation, conditioning skin situation fundamentally, when repairing skin, strengthen cellular immunity, have non-stimulated, nontoxic, without anaphylaxis, whitening, wrinkle resistant, sun-proof, defying age, the effects such as moisturizing.Specially for small pox (acne), pockmark recover, skin damage reaches conditioning skin, promote blood microcirculation, suppress free radical, reduce melanocyte, effectively stop melanin route of synthesis, prevent the function of all kinds of skin diseases, Placenta caprae seu ovis hydrolyzed protein thing and hirudin are applied to skin care item and strengthen skin immunization and still belong at home the first.
The foregoing is only the preferred embodiment of the present invention, protection scope of the present invention is not limited in above-mentioned embodiment, and every technical scheme that belongs to the principle of the invention all belongs to protection scope of the present invention.For a person skilled in the art, some improvements and modifications of carrying out under the prerequisite that does not depart from principle of the present invention, these improvements and modifications also should be considered as protection scope of the present invention.
Claims (5)
1. the light trace of biological anti-acne is repaired breast, it is characterized in that being comprised of following formula according to weight ratio: Placenta caprae seu ovis hydrolyzed protein thing: 10-20 gram, hirudin: 5-10 gram; Interleukin II: 3-8 gram; Epidermal growth factor: 1-2 gram; Vitamin B6: 3-5 gram, VCE: 3-5 gram, sebum aminoacid: 6-10 gram, milk protein thing: 10-15 gram, amino acid humectant: 3-5 gram, hyaluronic acid: 2-3 gram, water: 15-25 gram.
2. the light trace of a kind of biological anti-acne according to claim 1 is repaired breast, it is characterized in that according to the optimization formula of raw material and weight ratio composed as follows: Placenta caprae seu ovis hydrolyzed protein thing: 10 grams, and hirudin: 5 grams; Interleukin II: 3 grams; Epidermal growth factor: 1 gram; Vitamin B6: 3 grams, VCE: 3 grams, sebum aminoacid: 6 grams, milk protein thing: 10 grams, amino acid humectant: 3 grams, hyaluronic acid: 2 grams, water: 15 grams.
3. the light trace of a kind of biological anti-acne according to claim 1 and 2 is repaired breast, it is characterized in that: described interleukin II is: lymphocyte interleukin II.
4. the light trace of a kind of biological anti-acne according to claim 1 is repaired breast, it is characterized in that: described water is tri-distilled water.
5. the light trace of a kind of biological anti-acne according to claim 1 is repaired breast, it is characterized in that: described hirudin, interleukin-2, epidermal growth factor are the dilatation solution of stock solution.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310551592.1A CN103550126A (en) | 2013-11-08 | 2013-11-08 | Biological acne-removing and scar-lightening repairing emulsion |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310551592.1A CN103550126A (en) | 2013-11-08 | 2013-11-08 | Biological acne-removing and scar-lightening repairing emulsion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103550126A true CN103550126A (en) | 2014-02-05 |
Family
ID=50004613
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310551592.1A Pending CN103550126A (en) | 2013-11-08 | 2013-11-08 | Biological acne-removing and scar-lightening repairing emulsion |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103550126A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104997651A (en) * | 2015-08-14 | 2015-10-28 | 广州雅您儿生物科技有限公司 | Cell activation and regeneration nutrient |
| CN105997559A (en) * | 2016-05-11 | 2016-10-12 | 南京泽丽生物技术有限公司 | Skin-beautifying and anti-pox composition and preparing method thereof |
| CN107510619A (en) * | 2017-09-06 | 2017-12-26 | 深圳肽之妃科技有限公司 | A kind of complex polypeptide facial mask and preparation method thereof |
| CN107519037A (en) * | 2017-09-06 | 2017-12-29 | 深圳肽之妃科技有限公司 | A kind of liquid facial mask containing polypeptide and preparation method thereof and application method |
| CN109381357A (en) * | 2018-12-13 | 2019-02-26 | 广州宝莱生物科技有限公司 | A kind of anti-acne moisturizing leech freeze-dried powder |
| CN111067839A (en) * | 2020-01-16 | 2020-04-28 | 广东丽姿生物科技有限公司 | Conditioning repairing agent and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1522689A (en) * | 2003-09-12 | 2004-08-25 | 周维海 | Leech extract cosmetics and method for making same |
| CN102307561A (en) * | 2008-06-30 | 2012-01-04 | 奥夫莱夫塔埃克尼公司 | Use of plant-derived recombinant growth factors in skin care |
-
2013
- 2013-11-08 CN CN201310551592.1A patent/CN103550126A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1522689A (en) * | 2003-09-12 | 2004-08-25 | 周维海 | Leech extract cosmetics and method for making same |
| CN102307561A (en) * | 2008-06-30 | 2012-01-04 | 奥夫莱夫塔埃克尼公司 | Use of plant-derived recombinant growth factors in skin care |
Non-Patent Citations (2)
| Title |
|---|
| 邹全明 等: "《基因工程技术在美容保健品中的应用》", 《第十届东南亚地区医学美容学术交流大会论文汇编》, 31 December 2006 (2006-12-31), pages 8 - 11 * |
| 阮传良 等: "《若干生化产品在功效化妆品开发中的应用》", 《2007（第六届）中国日用化学工业研讨会论文集》, 31 December 2007 (2007-12-31), pages 75 - 82 * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104997651A (en) * | 2015-08-14 | 2015-10-28 | 广州雅您儿生物科技有限公司 | Cell activation and regeneration nutrient |
| CN105997559A (en) * | 2016-05-11 | 2016-10-12 | 南京泽丽生物技术有限公司 | Skin-beautifying and anti-pox composition and preparing method thereof |
| CN107510619A (en) * | 2017-09-06 | 2017-12-26 | 深圳肽之妃科技有限公司 | A kind of complex polypeptide facial mask and preparation method thereof |
| CN107519037A (en) * | 2017-09-06 | 2017-12-29 | 深圳肽之妃科技有限公司 | A kind of liquid facial mask containing polypeptide and preparation method thereof and application method |
| CN107510619B (en) * | 2017-09-06 | 2020-11-24 | 深圳肽之妃科技有限公司 | Composite polypeptide mask and preparation method thereof |
| CN109381357A (en) * | 2018-12-13 | 2019-02-26 | 广州宝莱生物科技有限公司 | A kind of anti-acne moisturizing leech freeze-dried powder |
| CN109381357B (en) * | 2018-12-13 | 2021-09-03 | 广州宝莱生物科技有限公司 | Leech freeze-dried powder capable of removing acne and moisturizing skin |
| CN111067839A (en) * | 2020-01-16 | 2020-04-28 | 广东丽姿生物科技有限公司 | Conditioning repairing agent and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103550126A (en) | Biological acne-removing and scar-lightening repairing emulsion | |
| Pan et al. | Placental therapy: An insight to their biological and therapeutic properties | |
| CN104173251B (en) | A kind of bone glue of yak former peptide cleawhite pack and preparation method thereof | |
| CN103271837B (en) | Biological activity cosmetic formulations and preparation method thereof | |
| CN103550117A (en) | Beauty and skin care product capable of promoting skin repairation and regeneration as well as preparation method and application thereof | |
| CN113332162B (en) | protamine-PDRN compound, composition and application in preparation of skin care product | |
| KR20160064410A (en) | Composition comprising spicules for skin care | |
| CN1259034C (en) | Leech extract cosmetics and method for making same | |
| CN105193673B (en) | A kind of clear acne repairs liquid and preparation method thereof | |
| CN113318058A (en) | Collagen supplement, autologous collagen liquid for radiofrequency cosmetology, and use method and application thereof | |
| CN105616184A (en) | Hyaluronic acid-polypeptide bonded conjugate mask and preparation method thereof | |
| CN108261367A (en) | A kind of anti-aging moisturizing essence and preparation method thereof | |
| CN109745618A (en) | A kind of restorative procedure of striae of pregnancy | |
| CN103690393B (en) | Skin-whitening anti-wrinkle biological silk mask | |
| CN108498357A (en) | A kind of human-like collagen facial mask liquid and preparation method thereof | |
| CN110368347A (en) | Anti-ageing reparation double-layer bi-color essence of one kind and preparation method thereof | |
| CN104546591A (en) | Plant essential oil facial mask and preparation method thereof | |
| CN110522712A (en) | A kind of bad face maintenance essence and preparation method | |
| CN103705394B (en) | Anti-acne disappears the biological silk mask of trace | |
| CN100546564C (en) | Chinese medicine melon and fruit beauty treatment flush coat cream and preparation method | |
| CN103520708A (en) | Composition capable of promoting wound healing and reducing scarring | |
| CN111067860A (en) | Stem cell secretion factor mask for whitening skin and fading acne marks and preparation method thereof | |
| CN108309840A (en) | A kind of profession repair membrane facial mask liquid and preparation method thereof | |
| CN104721126A (en) | Revitalizing and repairing essence and production method of revitalizing and repairing essence preparation | |
| CN106309172A (en) | Anti-aging eye essence liquid containing biological compound peptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: GUANGDONG LIZI BIOLOGICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: WANG HONGBO Effective date: 20150709 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20150709 Address after: 528300, No. 9, building 1, 1-2 East Avenue, Ronggui Desheng neighborhood committee, Shunde District, Foshan, Guangdong Applicant after: Guangdong Lizi Biotechnology Co., Ltd. Address before: Garden Road Shunde District Ronggui street 528303 Silver City Sports in Guangdong province Foshan city 3 Building No. 201 Applicant before: Wang Hongbo |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140205 |